Dimensional Fund Advisors
KRTX

Dimensional Fund Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Dimensional Fund Advisors’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-51,891
Closed -$16.4M – 3445
2023
Q4 		$16.4M Buy
51,891
+10,334
+25% +$2.01M ﹤0.01% 2085
2023
Q3 		$7.03M Sell
41,557
-22,207
-35% -$4.18M ﹤0.01% 2411
2023
Q2 		$13.8M Sell
63,764
-2,733
-4% -$586K ﹤0.01% 2111
2023
Q1 		$12.1M Sell
66,497
-65,331
-50% -$12.5M ﹤0.01% 2148
2022
Q4 		$25.9K Buy
131,828
+10,963
+9% +$2.35M 0.01% 1727
2022
Q3 		$27.2M Sell
120,865
-10,728
-8% -$2.17M 0.01% 1645
2022
Q2 		$16.6M Sell
131,593
-50,370
-28% -$5.79M 0.01% 1969
2022
Q1 		$23.1M Sell
181,963
-19,694
-10% -$2.22M 0.01% 1894
2021
Q4 		$26.4M Buy
201,657
+19,801
+11% +$2.56M 0.01% 1835
2021
Q3 		$22.2M Buy
181,856
+74,753
+70% +$8.63M 0.01% 1948
2021
Q2 		$12.2M Buy
+107,103
New +$12.5M ﹤0.01% 2269

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Dimensional Fund Advisors's KRTX Position: Q1 2024 in Review

Dimensional Fund Advisors sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 51,891 shares — an estimated $16.4M sold.

Dimensional Fund Advisors first reported a position in KRTX in Q2 2021 and held it in 11 quarters. The position peaked at $27.2M in Q3 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Dimensional Fund Advisors reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 51,891 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $16.4M.
  • Dimensional Fund Advisors first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2021 and held it in 11 quarters.
  • Dimensional Fund Advisors's Karuna Therapeutics, Inc. Common Stock position peaked at $27.2M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Dimensional Fund Advisors's 13F filing for Q1 2024, filed 10 May 2024.